176,949 Shares in Rapid Micro Biosystems, Inc. $RPID Acquired by Informed Momentum Co LLC

Key Points

• Informed Momentum Co LLC acquired a new stake in Rapid Micro Biosystems, purchasing 176,949 shares valued at approximately $467,000 during the first quarter.
• Rapid Micro Biosystems stock has seen a significant rise, up 8.6%, and has a market capitalization of $127.55 million, with a 12-month trading range between $0.80 and $4.50.
• The company reported an EPS of ($0.27) for the last quarter, missing expectations, but achieved revenue of $7.26 million, slightly above estimates.

Informed Momentum Co LLC bought a new position in shares of Rapid Micro Biosystems, Inc. (NASDAQ:RPID - Free Report) in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm bought 176,949 shares of the company's stock, valued at approximately $467,000. Informed Momentum Co LLC owned approximately 0.41% of Rapid Micro Biosystems at the end of the most recent quarter.

Several other institutional investors have also recently made changes to their positions in RPID. Evernest Financial Advisors LLC purchased a new position in Rapid Micro Biosystems during the 1st quarter valued at approximately $347,000. Renaissance Technologies LLC grew its holdings in Rapid Micro Biosystems by 122.9% during the 4th quarter. Renaissance Technologies LLC now owns 183,087 shares of the company's stock valued at $165,000 after buying an additional 100,942 shares in the last quarter. Citadel Advisors LLC purchased a new position in Rapid Micro Biosystems during the 4th quarter valued at approximately $65,000. Essex Investment Management Co. LLC purchased a new position in Rapid Micro Biosystems during the 1st quarter valued at approximately $166,000. Finally, Legato Capital Management LLC purchased a new position in Rapid Micro Biosystems during the 1st quarter valued at approximately $41,000. Hedge funds and other institutional investors own 52.60% of the company's stock.

Analyst Ratings Changes

Separately, Lake Street Capital started coverage on shares of Rapid Micro Biosystems in a report on Monday, July 28th. They issued a "buy" rating and a $8.00 target price on the stock.

Rapid Micro Biosystems Price Performance

Shares of Rapid Micro Biosystems stock traded up $0.08 during trading hours on Monday, reaching $2.70. The company's stock had a trading volume of 36,202 shares, compared to its average volume of 281,419. The stock has a market cap of $118.12 million, a P/E ratio of -2.67 and a beta of 1.32. The firm has a 50 day moving average price of $3.45 and a 200-day moving average price of $2.98. Rapid Micro Biosystems, Inc. has a one year low of $0.80 and a one year high of $4.50.

Rapid Micro Biosystems (NASDAQ:RPID - Get Free Report) last announced its earnings results on Tuesday, August 12th. The company reported ($0.27) EPS for the quarter, missing analysts' consensus estimates of ($0.26) by ($0.01). The company had revenue of $7.26 million during the quarter, compared to analysts' expectations of $7.10 million. Rapid Micro Biosystems had a negative return on equity of 63.07% and a negative net margin of 145.63%. As a group, sell-side analysts forecast that Rapid Micro Biosystems, Inc. will post -1.1 EPS for the current fiscal year.

Insider Activity at Rapid Micro Biosystems

In other news, CEO Robert G. Jr. Spignesi sold 11,881 shares of Rapid Micro Biosystems stock in a transaction that occurred on Monday, July 14th. The stock was sold at an average price of $3.32, for a total value of $39,444.92. Following the completion of the transaction, the chief executive officer owned 970,550 shares in the company, valued at approximately $3,222,226. The trade was a 1.21% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. In the last three months, insiders sold 57,443 shares of company stock valued at $195,952. 29.96% of the stock is currently owned by insiders.

Rapid Micro Biosystems Company Profile

Rapid Micro Biosystems, Inc, a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, medical devices, and personal care products in the United States, Germany, Switzerland, Japan, and internationally. The company offers Growth Direct platform, which includes Growth Direct system, proprietary consumables, lab information management system connection software, and customer support and validation services.